Fierce Pharma

Fierce Pharma is a B2B trade publication owned by Questex, itself a portfolio company of the private equity firm MidOcean Partners. Its coverage is oriented toward pharmaceutical industry professionals — executives, analysts, and researchers — not general consumers, and it does not take partisan editorial positions. On Trump administration policies such as drug pricing executive orders, FDA leadership changes, and tariff impacts on pharma supply chains, it reports factually and from an industry-impact perspective without consistent advocacy for or against the administration.